Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study (ATO-SR-DM)

This study has been completed.
Sponsor:
Collaborator:
American Diabetes Association
Information provided by:
Harvard Pilgrim Health Care
ClinicalTrials.gov Identifier:
NCT00790530
First received: November 11, 2008
Last updated: NA
Last verified: November 2008
History: No changes posted

November 11, 2008
November 11, 2008
June 2006
October 2007   (final data collection date for primary outcome measure)
Completion of dilated eye examination [ Time Frame: 12-months following intervention ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
  • Completion of glycated hemoglobin testing (HbA1c) [ Time Frame: one-year following intervention ] [ Designated as safety issue: No ]
  • Completion of LDL-cholesterol testing [ Time Frame: one year following intervention ] [ Designated as safety issue: No ]
  • Completion of microalbumin testing [ Time Frame: one-year following intervention ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study
Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study

The purpose of this study is to evaluate the effectiveness of automated telephone outreach with speech recognition to improve diabetes care.

Randomly allocate a total of 1200 health plan members with diabetes to automated telephone outreach with speech recognition (ATO-SR; N = 600) or usual care (N = 600). The intervention is a series of three calls, using automated calls, originating from the health plan, using interactive speech recognition technology, spaced approximately 4-6 weeks apart, to encourage participants to fulfill the recommended testing (dilated eye examinations, glycated hemoglobin, LDL-cholesterol, microalbumin) that had not been performed received in the preceding year.

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Diabetes Mellitus
  • Behavioral: Automated Telephone Outreach with Speech Recognition
    Automated Telephone Outreach with Speech Recognition
  • Other: Usual Care
    Usual Care
  • Experimental: ATO-SR
    Automated Telephone Outreach with Speech Recognition
    Intervention: Behavioral: Automated Telephone Outreach with Speech Recognition
  • No Intervention: Usual Care
    Usual Care
    Intervention: Other: Usual Care
Simon SR, Trinacty CM, Soumerai SB, Piette JD, Meigs JB, Shi P, Ensroth A, Ross-Degnan D. Improving diabetes care among patients overdue for recommended testing: a randomized controlled trial of automated telephone outreach. Diabetes Care. 2010 Jul;33(7):1452-3. doi: 10.2337/dc09-2332. Epub 2010 Mar 31.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1200
October 2007
October 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age 18 years or older
  • Diabetes, defined as either 1) filled a prescription for insulin or an oral hypoglycemic agent; or, 2) had two outpatient or one inpatient or two outpatients encounter claims with an ICD9-CM or CPT code indicating diabetes.
  • Gap in a key diabetes management metric as evidenced by no claim for a dilated eye examination in the prior 15 months and no claim for one or more of the following tests: glycated hemoglobin, LDL-cholesterol, or microalbumin. (Individuals with evidence of having received ACE-inhibitors or angiotensin receptor blockers were considered to have had a microalbumin test.)

Exclusion Criteria:

  • No primary care clinician in the data base
  • Those who had previously asked the health plan to exclude them from research or quality improvement
  • Women whose claim records contained diagnoses suggesting gestational diabetes
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00790530
1-05-JF-40
No
Steven R. Simon, Principal Investigator, Harvard Pilgrim Health Care
Harvard Pilgrim Health Care
American Diabetes Association
Principal Investigator: Steven R Simon, MD Harvard Pilgrim Health Care
Harvard Pilgrim Health Care
November 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP